Preoperative Serum Soluble Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin Predict Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Valve Surgery
- 30 September 2013
- journal article
- research article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 96 (3), 800-806
- https://doi.org/10.1016/j.athoracsur.2013.04.042
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- New-Onset Postoperative Atrial Fibrillation Predicts Late Mortality After Mitral Valve SurgeryThe Annals of Thoracic Surgery, 2011
- Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosisJournal of Internal Medicine, 2011
- Postoperative Atrial FibrillationISRN Cardiology, 2011
- Osteoprotegerin Predicts Progression of Chronic Heart Failure: Results From CORONACirculation: Heart Failure, 2011
- Osteoprotegerin: A Biomarker With Many FacesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Biomarkers of the Osteoprotegerin PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Relation of Multiple Inflammatory Biomarkers to Incident Atrial FibrillationThe American Journal of Cardiology, 2009
- Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart FailureCirculation, 2005
- A Multicenter Risk Index for Atrial Fibrillation After Cardiac SurgeryJAMA, 2004
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureThe New England Journal of Medicine, 2002